UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006823
Receipt number	R000008068
Scientific Title	Phase II study of S-1 plus irinotecan combined with biweekly cetuximab as 2nd-line chemotherapy in patients with wild type KRAS unresectable colorectal cancer, who had previously received oxaliplatin-based chemoterapy without CV port. (FUTURE 1103 STUDY)
Date of disclosure of the study information	2011/12/03
Last modified on	2023/09/01 16:54:32

---